{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:43:22Z","timestamp":1791315802533,"version":"4.3.1"},"reference-count":100,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Subacute sclerosing panencephalitis (SSPE) is a late-onset, intractable, and fatal viral disease caused by persistent infection of the central nervous system by a mutant strain of the measles virus. Ribavirin intracerebroventricular therapy has already been administered to several SSPE patients in Japan based on fundamental and clinical research findings from our group, with positive therapeutic effects reported in some patients. However, the efficacy of this treatment approach has not been unequivocally established. Hence, development of more effective therapeutic methods using new antiviral agents is urgently needed. This review describes the current status of SSPE treatment and research, highlighting promising approaches to the development of more effective therapeutic methods.<\/jats:p>","DOI":"10.3390\/molecules26020427","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T12:44:05Z","timestamp":1610714645000},"page":"427","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Advances in Antiviral Therapy for Subacute Sclerosing Panencephalitis"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7186-7603","authenticated-orcid":false,"given":"Koichi","family":"Hashimoto","sequence":"first","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Fukushima Medical University, Fukushima 9601295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1626-3625","authenticated-orcid":false,"given":"Mitsuaki","family":"Hosoya","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medicine, Fukushima Medical University, Fukushima 9601295, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"ref_1","unstructured":"(2020, November 01). WHO Immunization, Vaccines and Biologicals, Measles. Available online: https:\/\/www.who.int\/immunization\/diseases\/measles\/en\/."},{"key":"ref_2","unstructured":"(2020, November 01). WHO New Measles Surveillance Data for 2019. Available online: https:\/\/www.who.int\/news\/item\/15-05-2019-new-measles-surveillance-data-for-2019."},{"key":"ref_3","unstructured":"Cherry, J., Demmler-Harrison, G.J., Kaplan, S.L., Steinbach, W.J., and Hotez, P.J. (2019). Feigin and Cherry\u2019s Textbook of Pediatric Infectious Disease. Measles Virus, Elesevier. [8th ed.]."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1542\/peds.59.4.505","article-title":"Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis","volume":"59","author":"Modlin","year":"1977","journal-title":"Pediatrics"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1001\/jama.1969.03150250078007","article-title":"Subacute sclerosing panencephalitis. A multidisciplinary study of eight cases","volume":"207","author":"Jabbour","year":"1969","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ana.410110407","article-title":"Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex","volume":"11","author":"Dyken","year":"1982","journal-title":"Ann. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3988\/jcn.2014.10.4.354","article-title":"Fulminant subacute sclerosing panencephalitis presenting with acute ataxia and hemiparesis in a 15-year-old boy","volume":"10","author":"Kandadai","year":"2014","journal-title":"J. Clin. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.braindev.2006.01.008","article-title":"Long term survival in subacute sclerosing panencephalitis: An enigma","volume":"28","author":"Prashanth","year":"2006","journal-title":"Brain Dev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archneur.1979.00500460044004","article-title":"The variable natural history of subacute sclerosing panencephalitis: A study of 118 cases from the Middle East","volume":"36","author":"Risk","year":"1979","journal-title":"Arch. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1177\/0883073811436250","article-title":"Survey of subacute sclerosing panencephalitis in Japan","volume":"27","author":"Abe","year":"2012","journal-title":"J. Child Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/ije\/dym207","article-title":"Review of the effect of measles vaccination on the epidemiology of SSPE","volume":"36","author":"Campbell","year":"2007","journal-title":"Int. J. Epidemiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1086\/497169","article-title":"Subacute sclerosing panencephalitis: More cases of this fatal disease are prevented by measles immunization than was previously recognized","volume":"192","author":"Bellini","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Schonberger, K., Ludwig, M.S., Wildner, M., and Weissbrich, B. (2013). Epidemiology of subacute sclerosing panencephalitis (SSPE) in Germany from 2003 to 2009: A risk estimation. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0068909"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/cid\/cix302","article-title":"Subacute Sclerosing Panencephalitis: The Devastating Measles Complication That Might Be More Common Than Previously Estimated","volume":"65","author":"Wendorf","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","first-page":"1","article-title":"Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"47","author":"Watson","year":"1998","journal-title":"MMWR Recomm. Rep."},{"key":"ref_16","first-page":"7","article-title":"Cellular Inclusions in Cerebral Lesions of Lethargic Encephalitis","volume":"9","author":"Dawson","year":"1933","journal-title":"Am. J. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/221974a0","article-title":"Subacute sclerosing panencephalitis: Isolation of measles virus from a brain biopsy","volume":"221","author":"Fuccillo","year":"1969","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM196909112811103","article-title":"Isolation of measles virus from cell cultures of brain from a patient with subacute sclerosing panencephalitis","volume":"281","author":"Payne","year":"1969","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.coviro.2012.10.008","article-title":"Host factors and measles virus replication","volume":"2","author":"Delpeut","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"ref_20","first-page":"3","article-title":"Making it to the synapse: Measles virus spread in and among neurons","volume":"330","author":"Young","year":"2009","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1128\/JVI.02166-17","article-title":"Cell-to-Cell Measles Virus Spread between Human Neurons Is Dependent on Hemagglutinin and Hyperfusogenic Fusion Protein","volume":"92","author":"Sato","year":"2018","journal-title":"J. Virol."},{"key":"ref_22","unstructured":"Griffin, D.E. (2013). Measles Virus, Wolters Kluwer. [6th ed.]."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1128\/jvi.53.3.908-919.1985","article-title":"Measles virus P gene codes for two proteins","volume":"53","author":"Bellini","year":"1985","journal-title":"J. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0042-6822(03)00537-3","article-title":"The C protein of measles virus inhibits the type I interferon response","volume":"315","author":"Shaffer","year":"2003","journal-title":"Virology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1128\/JVI.02342-10","article-title":"The measles virus V protein binds to p65 (RelA) to suppress NF-kappaB activity","volume":"85","author":"Schuhmann","year":"2011","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1348-0421.2001.tb01315.x","article-title":"Paramyxovirus accessory proteins as interferon antagonists","volume":"45","author":"Gotoh","year":"2001","journal-title":"Microbiol. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1574-6976.2012.00330.x","article-title":"Measles virus, immune control, and persistence","volume":"36","author":"Griffin","year":"2012","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_28","unstructured":"Lamb, R.A., and Parks, G.D. (2013). Paramyxoviridae: The Viruses and Their Replication, Lippincott, Williams, and Wilkins. [6th ed.]."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Plattet, P., Alves, L., Herren, M., and Aguilar, H.C. (2016). Measles Virus Fusion Protein: Structure, Function and Inhibition. Viruses, 8.","DOI":"10.3390\/v8040112"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.virusres.2005.04.005","article-title":"Molecular mechanisms of measles virus persistence","volume":"111","author":"Rima","year":"2005","journal-title":"Virus Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1128\/JVI.02632-12","article-title":"Mutant fusion proteins with enhanced fusion activity promote measles virus spread in human neuronal cells and brains of suckling hamsters","volume":"87","author":"Watanabe","year":"2013","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1128\/JVI.03346-14","article-title":"Measles virus mutants possessing the fusion protein with enhanced fusion activity spread effectively in neuronal cells, but not in other cells, without causing strong cytopathology","volume":"89","author":"Watanabe","year":"2015","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1128\/JVI.03117-12","article-title":"Characteristics of viruses derived from nude mice with persistent measles virus infection","volume":"87","author":"Abe","year":"2013","journal-title":"J. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/13550280290100752","article-title":"Characterization of measles virus strains causing SSPE: A study of 11 cases","volume":"8","author":"Jin","year":"2002","journal-title":"J. Neurovirol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1099\/0022-1317-76-5-1173","article-title":"Temporal and geographical distribution of measles virus genotypes","volume":"76","author":"Rima","year":"1995","journal-title":"J. Gen. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/35022579","article-title":"SLAM (CDw150) is a cellular receptor for measles virus","volume":"406","author":"Tatsuo","year":"2000","journal-title":"Nature"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Noyce, R.S., Bondre, D.G., Ha, M.N., Lin, L.T., Sisson, G., Tsao, M.S., and Richardson, C.D. (2011). Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002240"},{"key":"ref_38","first-page":"4","article-title":"Adherens junction protein nectin-4 is the epithelial receptor for measles virus","volume":"480","author":"Mateo","year":"2011","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1128\/jvi.67.10.6025-6032.1993","article-title":"Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus","volume":"67","author":"Naniche","year":"1993","journal-title":"J. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0092-8674(93)80071-L","article-title":"The human CD46 molecule is a receptor for measles virus (Edmonston strain)","volume":"75","author":"Dorig","year":"1993","journal-title":"Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1212\/01.WNL.0000106940.95749.8E","article-title":"Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis","volume":"62","author":"Torisu","year":"2004","journal-title":"Neurology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/13550280802298120","article-title":"Association of toll-like receptor 3 gene polymorphism with subacute sclerosing panencephalitis","volume":"14","author":"Ishizaki","year":"2008","journal-title":"J. Neurovirol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.gene.2014.03.056","article-title":"May TLR4 Asp299Gly and IL17 His161Arg polymorphism be associated with progression of primary measles infection to subacute sclerosing panencephalitis?","volume":"547","author":"Piskin","year":"2014","journal-title":"Gene"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/13550280701455383","article-title":"Interleukin (IL)-12, IL-2, interferon-gamma gene polymorphisms in subacute sclerosing panencephalitis patients","volume":"13","author":"Yilmaz","year":"2007","journal-title":"J. Neurovirol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/archneur.59.5.822","article-title":"Contribution of the interleukin 4 gene to susceptibility to subacute sclerosing panencephalitis","volume":"59","author":"Inoue","year":"2002","journal-title":"Arch. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1089\/dna.2013.1997","article-title":"Association of interleukin 18, interleukin 2, and tumor necrosis factor polymorphisms with subacute sclerosing panencephalitis","volume":"32","author":"Piskin","year":"2013","journal-title":"DNA Cell Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1055\/s-0034-1378129","article-title":"Granzyme B gene polymorphism associated with subacute sclerosing panencephalitis","volume":"45","author":"Yentur","year":"2014","journal-title":"Neuropediatrics"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1055\/s-0033-1338134","article-title":"PD-1 gene polymorphism in children with subacute sclerosing panencephalitis","volume":"44","author":"Piskin","year":"2013","journal-title":"Neuropediatrics"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1007\/s12325-019-00995-6","article-title":"Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases","volume":"36","author":"Sliva","year":"2019","journal-title":"Adv. Ther."},{"key":"ref_50","first-page":"383","article-title":"Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy","volume":"32","author":"Sorkin","year":"1986","journal-title":"Drugs"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1212\/WNL.29.6.763","article-title":"Isoprinosine in subacute sclerosing panencephalitis","volume":"29","author":"Huttenlocher","year":"1979","journal-title":"Neurology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ana.410070216","article-title":"Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: A controlled study","volume":"7","author":"Haddad","year":"1980","journal-title":"Ann. Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S0140-6736(82)92097-9","article-title":"Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, non-randomised study in 98 patients","volume":"1","author":"Jones","year":"1982","journal-title":"Lancet"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1212\/WNL.42.3.488","article-title":"Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis","volume":"42","author":"Yalaz","year":"1992","journal-title":"Neurology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0387-7604(93)90120-W","article-title":"Combined oral isoprinosine-intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis","volume":"15","author":"Gascon","year":"1993","journal-title":"Brain Dev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1212\/WNL.48.2.526","article-title":"Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon","volume":"48","author":"Anlar","year":"1997","journal-title":"Neurology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/088307380301801201","article-title":"Randomized treatment study of inosiplex versus combined inosiplex and intraventricular interferon-alpha in subacute sclerosing panencephalitis (SSPE): International multicenter study","volume":"18","author":"Gascon","year":"2003","journal-title":"J. Child Neurol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s00415-008-0032-6","article-title":"Subacute sclerosing panencephalitis","volume":"255","author":"Garg","year":"2008","journal-title":"J. Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/glia.23154","article-title":"Type I interferon pathway in CNS homeostasis and neurological disorders","volume":"65","author":"Blank","year":"2017","journal-title":"Glia"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02339207","article-title":"Toxic effect of intraventricular interferon-alpha in subacute sclerosing panencephalitis","volume":"15","author":"Cianchetti","year":"1994","journal-title":"Ital. J. Neurol. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0166-3542(89)90072-7","article-title":"Inhibitory effect of selected antiviral compounds on measles (SSPE) virus replication in vitro","volume":"12","author":"Hosoya","year":"1989","journal-title":"Antivir. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1542\/peds.72.5.613","article-title":"Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants","volume":"72","author":"Taber","year":"1983","journal-title":"Pediatrics"},{"key":"ref_63","first-page":"305","article-title":"Treatment of respiratory viral infection in an immunodeficient infant with ribavirin aerosol","volume":"138","author":"McIntosh","year":"1984","journal-title":"Am. J. Dis. Child"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1001\/jama.1983.03330430047028","article-title":"Ribavirin aerosol treatment of influenza B virus infection","volume":"249","author":"McClung","year":"1983","journal-title":"JAMA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1128\/AAC.26.2.200","article-title":"Treatment of influenza A (H1N1) virus infection with ribavirin aerosol","volume":"26","author":"Wilson","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1128\/AAC.30.2.201","article-title":"Biochemistry and clinical applications of ribavirin","volume":"30","author":"Gilbert","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM198601023140104","article-title":"Lassa fever. Effective therapy with ribavirin","volume":"314","author":"McCormick","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/clinids\/19.3.454","article-title":"Severe measles pneumonitis in adults: Evaluation of clinical characteristics and therapy with intravenous ribavirin","volume":"19","author":"Forni","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0163-4453(90)91094-T","article-title":"Ribavirin response in measles pneumonia","volume":"20","author":"Gururangan","year":"1990","journal-title":"J. Infect."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/infdis\/159.4.748","article-title":"Oral ribavirin therapy for subacute sclerosing panencephalitis","volume":"159","author":"Ogle","year":"1989","journal-title":"J. Infect. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1128\/AAC.38.4.653","article-title":"Effect of ribavirin on subacute sclerosing panencephalitis virus infections in hamsters","volume":"38","author":"Honda","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/AAC.40.1.241","article-title":"Effective ribavirin concentration in hamster brains for antiviral chemotherapy for subacute sclerosing panencephalitis","volume":"40","author":"Ishii","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0166-3542(97)00055-7","article-title":"The cooperative effect of interferon-alpha and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivo","volume":"37","author":"Takahashi","year":"1998","journal-title":"Antivir. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/AAC.37.3.532","article-title":"Safety, tolerance, and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infection","volume":"37","author":"Connor","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1128\/AAC.45.3.943-945.2001","article-title":"High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis","volume":"45","author":"Hosoya","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0887-8994(00)00233-2","article-title":"Combined treatment with interferon-alpha and ribavirin for subacute sclerosing panencephalitis","volume":"24","author":"Tomoda","year":"2001","journal-title":"Pediatr. Neurol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/088307380201700911","article-title":"Treatment of subacute sclerosing panencephalitis with interferon-alpha, ribavirin, and inosiplex","volume":"17","author":"Solomon","year":"2002","journal-title":"J. Child Neurol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0387-7604(03)00062-7","article-title":"Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan","volume":"25","author":"Tomoda","year":"2003","journal-title":"Brain Dev."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1128\/AAC.48.12.4631-4635.2004","article-title":"Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis","volume":"48","author":"Hosoya","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/brain\/91.4.707","article-title":"Formation and absorption of cerebrospinal fluid in man","volume":"91","author":"Cutler","year":"1968","journal-title":"Brain"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archinte.1990.00390130145023","article-title":"Complications associated with Ommaya reservoirs in patients with cancer. The Princess Margaret Hospital experience and a review of the literature","volume":"150","author":"Lishner","year":"1990","journal-title":"Arch. Intern. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/INF.0000000000002181","article-title":"Maintaining Concentration of Ribavirin in Cerebrospinal Fluid by a New Dosage Method; 3 Cases of Subacute Sclerosing Panencephalitis Treated Using a Subcutaneous Continuous Infusion Pump","volume":"38","author":"Miyazaki","year":"2019","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s12028-011-9669-6","article-title":"Accidental intoxication with 60 mg intrathecal baclofen: Survived","volume":"16","author":"Berger","year":"2012","journal-title":"Neurocrit. Care"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1469-8749.2010.03717.x","article-title":"Subacute sclerosing panencephalitis: An update","volume":"52","author":"Gutierrez","year":"2010","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_85","first-page":"327647","article-title":"Role of carbamazepine in the symptomatic treatment of subacute sclerosing panencephalitis: A case report and review of the literature","volume":"2013","author":"Ravikumar","year":"2013","journal-title":"Case Rep. Neurol. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"43395","DOI":"10.1038\/srep43395","article-title":"GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses","volume":"7","author":"Lo","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1128\/AAC.00709-16","article-title":"Antiviral Activity of Favipiravir (T-705) against a Broad Range of Paramyxoviruses In Vitro and against Human Metapneumovirus in Hamsters","volume":"60","author":"Jochmans","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Hashimoto, K., Maeda, H., Miyazaki, K., Watanabe, M., Norito, S., Maeda, R., Kume, Y., Ono, T., Chishiki, M., and Suyama, K. (2020). Antiviral effect of favipiravir (T-705) against measles and subacute sclerosing panencephalitis viruses. Jpn. J. Infect. Dis.","DOI":"10.7883\/yoken.JJID.2020.481"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e00061","DOI":"10.1128\/mSphere.00061-15","article-title":"Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus","volume":"1","author":"Tani","year":"2016","journal-title":"mSphere"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1128\/AAC.00289-07","article-title":"Nonnucleoside inhibitor of measles virus RNA-dependent RNA polymerase complex activity","volume":"51","author":"White","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1128\/AAC.00503-09","article-title":"Target analysis of the experimental measles therapeutic AS-136A","volume":"53","author":"Yoon","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1021\/jm201699w","article-title":"Non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase: Synthesis, structure-activity relationships, and pharmacokinetics","volume":"55","author":"Ndungu","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/febs.14991","article-title":"Biophysical characterization and single-chain Fv construction of a neutralizing antibody to measles virus","volume":"287","author":"Tadokoro","year":"2020","journal-title":"FEBS J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/JVI.01826-12","article-title":"Mechanism for active membrane fusion triggering by morbillivirus attachment protein","volume":"87","author":"Ader","year":"2013","journal-title":"J. Virol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/JVI.03123-13","article-title":"Molecular determinants defining the triggering range of prefusion F complexes of canine distemper virus","volume":"88","author":"Avila","year":"2014","journal-title":"J. Virol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1073\/pnas.0308520101","article-title":"A target site for template-based design of measles virus entry inhibitors","volume":"101","author":"Plemper","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"13785","DOI":"10.1128\/JVI.02436-13","article-title":"Fatal measles virus infection prevented by brain-penetrant fusion inhibitors","volume":"87","author":"Welsch","year":"2013","journal-title":"J. Virol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Watanabe, M., Hashimoto, K., Abe, Y., Kodama, E.N., Nabika, R., Oishi, S., Ohara, S., Sato, M., Kawasaki, Y., and Fujii, N. (2016). A Novel Peptide Derived from the Fusion Protein Heptad Repeat Inhibits Replication of Subacute Sclerosing Panencephalitis Virus In Vitro and In Vivo. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0162823"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/2\/427\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:11:28Z","timestamp":1760159488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/2\/427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":100,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["molecules26020427"],"URL":"https:\/\/doi.org\/10.3390\/molecules26020427","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,15]]}}}